Safety and efficacy assessment of plerixafor in patients with multiple myeloma proven or predicted to be poor mobilizers, including assessment of tumor cell mobilization-Reference-Cited by-同舟云学术

Safety and efficacy assessment of plerixafor in patients with multiple myeloma proven or predicted to be poor mobilizers, including assessment of tumor cell mobilization

Published:2009-06-22 Issue:1 Volume:45 Page:63-68
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Tricot G,Cottler-Fox M H,Calandra G

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2009130.pdf

Reference25 articles.

1. Attal M, Harousseau J-L, Stoppa A-M, Sotto J-J, Fuzibet J-G, Rossi J-F et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med 1996; 335: 91–97.

2. Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 2003; 348: 1875–1883.

3. Fermand J-P, Katsahian S, Divine M, Leblond V, Dreyfus F, Macro M et al. High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55–65 years: long-term results of a randomized control trial from the group myelome-autogreffe. J Clin Oncol 2005; 23: 9227–9233.

4. Craig JI, Langlands K, Parker AC, Anthony RS . Molecular detection of tumor contamination in peripheral blood stem cell harvests. Exp Hematol 1994; 22: 898–902.

5. Gazitt Y, Reading CC, Hoffman R, Wickrema A, Vesole DH, Jagannath S et al. Purified CD34+ Lin− Thy+ stem cells do not contain clonal myeloma cells. Blood 1995; 86: 381–389.

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of plerixafor use in the mobilization of blood grafts for autologous hematopoietic cell transplantation;Transfusion;2024-02-26

2. Comparison of different plerixafor-based strategies for adequate hematopoietic stem cell collection in poor mobilizers;The European Research Journal;2023-11-04

3. Successful Stem Cell Mobilization and CD34+ Cell Collection in a Poor Mobilizer: A Case Report Utilizing a Combination of Recombinant Growth Colony Stimulating Factor, Recombinant Human Growth Factor, and Plerixafor;Journal of Research in Pharmacy Practice;2023-07

4. Stem cell mobilization in multiple myeloma: challenges, strategies, and current developments;Annals of Hematology;2023-03-22

5. Hematopoietic Stem Cell Transplantation: An Overview;Pulmonary and Critical Care Considerations of Hematopoietic Stem Cell Transplantation;2023